quinazolines has been researched along with Dermatitis, Contact, Phototoxic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doan, HQ; Goldstein, J; Hu, MI; Patel, AB; Piha-Paul, SA; Subbiah, V | 1 |
Qiu, XY; Yin, Y; Zhang, B; Zhang, YH | 1 |
Brun, P; Dall'Acqua, S; Salvador, A; Vedaldi, D | 1 |
Burke, NS; Dassanayake, S; Mealey, KL | 1 |
Fine, HA; Kong, HH; Stern, JB; Turner, ML | 1 |
Guitart, J; Lacouture, ME; Lai, SE; Luu, M; Patel, J | 1 |
1 review(s) available for quinazolines and Dermatitis, Contact, Phototoxic
Article | Year |
---|---|
Vandetanib photoinduced cutaneous toxicities.
Topics: Aged; Antineoplastic Agents; Dermatitis, Phototoxic; Drug Eruptions; Female; Humans; Male; Middle Aged; Piperidines; Quinazolines | 2019 |
5 other study(ies) available for quinazolines and Dermatitis, Contact, Phototoxic
Article | Year |
---|---|
A rare cutaneous phototoxic rash after vandetanib therapy in a patient with thyroid cancer: A case report.
Topics: Adult; Antineoplastic Agents; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Piperidines; Quinazolines; Thyroid Neoplasms | 2019 |
Vandetanib-induced phototoxicity in human keratinocytes NCTC-2544.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Survival; Dermatitis, Phototoxic; DNA Damage; Humans; Lysosomes; Mice; Mitochondria; Oxidation-Reduction; Piperidines; Protein Kinase Inhibitors; Quinazolines; Serum Albumin, Bovine; Thiobarbituric Acid Reactive Substances; Ultraviolet Rays | 2014 |
Tyrosine kinase inhibitors enhance ciprofloxacin-induced phototoxicity by inhibiting ABCG2.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Ciprofloxacin; Dermatitis, Phototoxic; Drug Synergism; Flow Cytometry; Gefitinib; Gene Expression Regulation; HEK293 Cells; Humans; Imatinib Mesylate; Neoplasm Proteins; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk Factors | 2014 |
Cutaneous pigmentation after photosensitivity induced by vandetanib therapy.
Topics: Aged; Antineoplastic Agents; Dermatitis, Phototoxic; Female; Humans; Hyperpigmentation; Middle Aged; Piperidines; Protein-Tyrosine Kinases; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Skin | 2009 |
Photosensitive rash due to the epidermal growth factor receptor inhibitor erlotinib.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dermatitis, Phototoxic; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines | 2007 |